Articles

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer

Imagin Gains Momentum; Positive Progress in Research Study

CGG: announces issuance of $300 million and €280 million First Lien Senior Secured Notes

Corbus Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

CrownBio Launches New Humanized Target Model for Immunotherapy

Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 | Business Wire

Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study | Business Wire

Agence européenne des médicaments - Trouver des médicaments - Stribild

Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018

Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada | Business Wire

UMICORE